SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-21-061496
Filing Date
2021-11-23
Accepted
2021-11-23 13:32:26
Documents
15
Period of Report
2021-11-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea151268-8k_inmedpharma.htm   iXBRL 8-K 38309
2 NEWS RELEASE, DATED NOVEMBER 23, 2021 ea151268ex99-1_inmedpharma.htm EX-99.1 8514
7 GRAPHIC ex99-1_001.jpg GRAPHIC 16784
  Complete submission text file 0001213900-21-061496.txt   272372

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE inm-20211123.xsd EX-101.SCH 3031
4 XBRL DEFINITION FILE inm-20211123_def.xml EX-101.DEF 26195
5 XBRL LABEL FILE inm-20211123_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE inm-20211123_pre.xml EX-101.PRE 22364
8 EXTRACTED XBRL INSTANCE DOCUMENT ea151268-8k_inmedpharma_htm.xml XML 3627
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 211437000
SIC: 2834 Pharmaceutical Preparations